Citius Oncology (CTOR) Interest Coverage Ratio (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Interest Coverage Ratio of 4.16 for Q1 2026, up 98.31% year-over-year from 2.1 in Q1 2025, and down 2533.13% quarter-over-quarter from 0.16 in Q4 2025.
Citius Oncology (CTOR) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Interest Coverage Ratio for 4 consecutive years, with 4.16 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 98.31% year-over-year to 4.16; the TTM figure through Mar 2026 stood at 6.32 (up 95.2% YoY), while the FY2025 annual figure was 4.37, down 149.14% from the prior year.
- Interest Coverage Ratio retreated to 4.16 in Q1 2026 per CTOR's latest filing, from 0.16 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.11 in Q2 2025 and bottomed at 246.03 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 60.7 across 4 years, with a median of 9.01 in 2024.
- On a YoY basis, Interest Coverage Ratio climbed as much as 99.93% in 2025 and fell as far as 5466.6% in 2025.
- Citius Oncology's Interest Coverage Ratio stood at 149.93 in 2023, then soared by 90.92% to 13.61 in 2024, then surged by 98.84% to 0.16 in 2025, then sank by 2533.13% to 4.16 in 2026.
- Business Quant data shows CTOR's Interest Coverage Ratio at 4.16 in Q1 2026, 0.16 in Q4 2025, and 35.75 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Citius Oncology | 81.12 Mn | 81.12 Mn | 1.00 Mn | -37.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.16 |
| Dec 31, 2025 | -0.16 |
| Sep 30, 2025 | -35.75 |
| Jun 30, 2025 | -0.11 |
| Mar 31, 2025 | -246.03 |
| Dec 31, 2024 | -13.61 |
| Jun 30, 2024 | -152.62 |
| Mar 31, 2024 | -4.42 |
| Dec 31, 2023 | -149.93 |
| Sep 30, 2023 | -0.19 |